A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s13300-020-00894-y
Published Online: 2020-07-28
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kalra, Sanjay
Sahay, Rakesh
Text and Data Mining valid from 2020-07-28
Version of Record valid from 2020-07-28
Article History
Received: 19 June 2020
First Online: 28 July 2020